Retrieved from Veronese, N., Cooper, C., Reginster, J
This impressive weight reduction with the various long-acting gut peptide-based therapies is largely believed to result from a reduced food/calorie intake, which results from decreased appetite and earlier and increased satiety, coupled with controlled and mindful eating
You may also notice that your recovery from hard training feels a bit more manageable
Insulin resistance, even in the absence of diabetes, can persist despite GLP-1 therapy and should be assessed via fasting insulin levels and HOMA-IR scoring
106 Despite stimulated glucose uptake, insulin rapidly reduces hepatic glucose output and hepatic glucose production (HGP) by activating glycogen synthesis, and suppressing glycogenolysis and gluconeogenesis in liver